Savara Inc

SVRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2010 FY2009 FY2008 FY2007 FY2006 FY2005 FY2004 FY2003
Revenue $489.0K
Cost of Revenue
Gross Profit $489.0K
Gross Margin 100.0%
Operating Expenses
Research & Development
SG&A Expense $5.0M
Operating Income $-8.5M
Operating Margin -1,746.5%
Interest Expense $1.6K
Pretax Income
Income Tax Expense
Net Income $-8.5M $-11.3M $-26.6M $-22.1M $-29.3M $-24.8M $-6.7M $-2.3M
Net Margin -1,728.3%
EPS (Basic) $-1.07
EPS (Diluted) $-1.07
Shares Outstanding (Basic) 15.5M
Shares Outstanding (Diluted) 15.5M
Dividends Per Share
← Newer Page 3 of 4 Older →